Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

521 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Progress and challenges in TB vaccine development.
Voss G, Casimiro D, Neyrolles O, Williams A, Kaufmann SHE, McShane H, Hatherill M, Fletcher HA. Voss G, et al. Among authors: kaufmann she. F1000Res. 2018 Feb 16;7:199. doi: 10.12688/f1000research.13588.1. eCollection 2018. F1000Res. 2018. PMID: 29568497 Free PMC article. Review.
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.
Williams A, Hatch GJ, Clark SO, Gooch KE, Hatch KA, Hall GA, Huygen K, Ottenhoff TH, Franken KL, Andersen P, Doherty TM, Kaufmann SH, Grode L, Seiler P, Martin C, Gicquel B, Cole ST, Brodin P, Pym AS, Dalemans W, Cohen J, Lobet Y, Goonetilleke N, McShane H, Hill A, Parish T, Smith D, Stoker NG, Lowrie DB, Källenius G, Svenson S, Pawlowski A, Blake K, Marsh PD. Williams A, et al. Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):29-38. doi: 10.1016/j.tube.2004.09.009. Epub 2005 Jan 20. Tuberculosis (Edinb). 2005. PMID: 15687025
Progress in tuberculosis vaccine development.
Baumann S, Nasser Eddine A, Kaufmann SH. Baumann S, et al. Curr Opin Immunol. 2006 Aug;18(4):438-48. doi: 10.1016/j.coi.2006.05.016. Epub 2006 Jun 13. Curr Opin Immunol. 2006. PMID: 16777396 Review.
Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
Tchilian EZ, Desel C, Forbes EK, Bandermann S, Sander CR, Hill AV, McShane H, Kaufmann SH. Tchilian EZ, et al. Infect Immun. 2009 Feb;77(2):622-31. doi: 10.1128/IAI.00685-08. Epub 2008 Dec 8. Infect Immun. 2009. PMID: 19064635 Free PMC article.
Tuberculosis vaccine development at a divide.
Kaufmann SH. Kaufmann SH. Curr Opin Pulm Med. 2014 May;20(3):294-300. doi: 10.1097/MCP.0000000000000041. Curr Opin Pulm Med. 2014. PMID: 24626237 Review.
Big Data in Vaccinology: Introduction and section summaries.
Kaufmann SH, Fletcher HA, Guzmán CA, Ottenhoff TH. Kaufmann SH, et al. Vaccine. 2015 Sep 29;33(40):5237-40. doi: 10.1016/j.vaccine.2015.04.078. Epub 2015 May 2. Vaccine. 2015. PMID: 25939278 No abstract available.
A blood RNA signature for tuberculosis disease risk: a prospective cohort study.
Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, Mahomed H, Erasmus M, Whatney W, Hussey GD, Abrahams D, Kafaar F, Hawkridge T, Verver S, Hughes EJ, Ota M, Sutherland J, Howe R, Dockrell HM, Boom WH, Thiel B, Ottenhoff THM, Mayanja-Kizza H, Crampin AC, Downing K, Hatherill M, Valvo J, Shankar S, Parida SK, Kaufmann SHE, Walzl G, Aderem A, Hanekom WA; ACS and GC6-74 cohort study groups. Zak DE, et al. Among authors: kaufmann she. Lancet. 2016 Jun 4;387(10035):2312-2322. doi: 10.1016/S0140-6736(15)01316-1. Epub 2016 Mar 24. Lancet. 2016. PMID: 27017310 Free PMC article.
521 results